Roble, Belko & Company, Inc Medtronic PLC Transaction History
Roble, Belko & Company, Inc
- $629 Million
- Q4 2024
A detailed history of Roble, Belko & Company, Inc transactions in Medtronic PLC stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 14 shares of MDT stock, worth $1,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$1,279
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MDT
# of Institutions
2,285Shares Held
1.02BCall Options Held
8.05MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA123MShares$11.3 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY112MShares$10.2 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.7MShares$5.55 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA32.6MShares$2.98 Billion0.63% of portfolio
-
Jpmorgan Chase & CO New York, NY30.7MShares$2.81 Billion0.23% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $121B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...